Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

C14orf131 Inhibitors

However, if we were to consider a class of compounds known as "C14orf131 inhibitors," these would be molecules designed to interact with and inhibit the function of the protein product encoded by the C14orf131 gene. The process of designing such inhibitors would begin with a detailed understanding of the protein's structure and function. Scientists would need to clarify the role that the C14orf131 protein plays within the cell, identify the active or binding sites crucial for its function, and understand the implications of modulating its activity. Structural biology techniques, including X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy, could be vital in mapping the three-dimensional structure of the protein, which would, in turn, facilitate the design of molecules that could specifically bind to and inhibit the protein.

Once potential binding sites on the C14orf131 protein are identified, chemists could utilize computational modeling to screen for molecules that fit these sites. High-throughput screening of chemical libraries might also be employed to find initial lead compounds with inhibitory activity against the protein. Subsequent steps would involve the synthesis and modification of these lead compounds to improve their specificity and potency as inhibitors. A critical aspect of this process would be to ensure that the compounds are selective for C14orf131 and do not interact with other proteins, especially those with similar structures or functions. Furthermore, the physicochemical properties of these inhibitors-such as their stability, solubility, and ability to cross cellular membranes-would be optimized to ensure effective interaction with the C14orf131 protein in its native cellular context. Throughout this process, a multidisciplinary approach integrating computational chemistry, molecular biology, and biochemistry would be essential to develop and refine these inhibitory compounds.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor that can affect various signaling pathways and potentially downregulate ZNF839 gene transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Histone deacetylase inhibitor that can alter chromatin accessibility and potentially decrease ZNF839 transcription.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$214.00
$622.00
1
(1)

Another histone deacetylase inhibitor that could modulate chromatin structure and affect ZNF839 expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor that could affect transcription factor activity and potentially downregulate ZNF839 expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

DNA methyltransferase inhibitor that may alter the methylation status of the ZNF839 gene promoter, potentially reducing expression.

Chaetocin

28097-03-2sc-200893
200 µg
$120.00
5
(1)

Disrupts hypoxia-inducible factor (HIF) transcriptional activity, possibly affecting ZNF839 expression under hypoxic conditions.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Exhibits multiple effects on cellular pathways that could include the downregulation of ZNF839 expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor that could impede the MAPK/ERK pathway, potentially affecting ZNF839 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that might reduce ZNF839 expression by altering AKT signaling pathways.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$56.00
$212.00
$764.00
24
(1)

p53 stabilizer that could influence the expression of a range of genes, possibly including ZNF839, through p53 response elements.